Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673

European Journal of Medicinal Chemistry 2026

View at publisher
Authors: Xilin Lyu, Zhiyi Wang, Yanyan Shen, Xiancheng Wang, Yixuan Wang, Shumeng Yu, Biyu Yang, Ziqin Yan, Shijie Zhang, Yuhang Lu, He Huang, Yi Chen
+1 more Yujun Zhao
DOI: 10.1016/j.ejmech.2026.118921
Cited by: 1
References: 40

Fields of Study & Subjects

Sarcoma Diagnosis and Treatment Acute Myeloid Leukemia Research Angiogenesis and VEGF in Cancer

Publication details

Journal / source
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Volume
314
Pages
118921–118921
Publication date
2 May 2026
Language
EN